A vaccine is disclosed which is useful for protecting a host from Gram negative
infections and the effects of endotoxin, therefore preventing sepsis and septic
shock. The vaccine is prepared by combining LPS free or in conjugate form with
a stoichiometric excess of a peptide of the formula:
(a) (A)n wherein A is Lysine or Arginine and n is an integer
with a minimum value of 7;
(b) (AB)m wherein A is Lysine or Arginine and B is a hydrophobic
amino acid selected from the group consisting of Valine, Leucine, Isoleucine, Tyrosine,
Phenylalanine and Tryptophan; m is an integer with a minimum value of 3; and
(c) (ABC)p wherein A is a cationic amino acid which is Lysine
or Arginine; B and C are hydrophobic amino acids which may be the same or different
and are selected from the group consisting of Valine, Leucine, Isoleucine, Tyrosine,
Phenylalanine and Tryptophan; p is an integer with a minimum value of 2.
|
|
|